My understanding is they don't want these types of stories jeopardizing the trials via it creating spikes in the placebo effect. I think the more likely interpretation is they're trying to balance the trial recruitment process (rather than short term share price) to ensure there are no additional delays.
Breakthrough arthritis treatments will be available in five years, page-18
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.060(29.3%) |
Mkt cap ! $92.81M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 26.5¢ | 21.0¢ | $862.8K | 3.580M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7500 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |